267 related articles for article (PubMed ID: 7535432)
21. Differential effects of the hematopoietic inhibitors MIP-1 alpha, TGF-beta, and TNF-alpha on cytokine-induced proliferation of subpopulations of CD34+ cells purified from cord blood and fetal liver.
Mayani H; Little MT; Dragowska W; Thornbury G; Lansdorp PM
Exp Hematol; 1995 May; 23(5):422-7. PubMed ID: 7536684
[TBL] [Abstract][Full Text] [Related]
22. CD34 positive cell selection by immunomagnetic techniques.
Bigas A; Amill B; Canals C; Tugues D; García J
Prog Clin Biol Res; 1992; 377():545-51. PubMed ID: 1279723
[No Abstract] [Full Text] [Related]
23. Estimation of peripheral blood CD34+ cells for autologous transplantation in cancer patients.
Siena S; Bregni M; Gianni AM
Exp Hematol; 1993 Feb; 21(2):203-5. PubMed ID: 7678809
[No Abstract] [Full Text] [Related]
24. CD34 analysis in erythropoietin mobilized peripheral blood stem cells.
O'Kane-Murphy B; Jackson JD; Kuszynski C; Costas P; Wang PN; Warkentin PI; Kessinger A
Prog Clin Biol Res; 1994; 389():371-6. PubMed ID: 7535444
[No Abstract] [Full Text] [Related]
25. Kinetics of low and high dose granulocyte/macrophage colony stimulating factor mobilization of peripheral blood stem cells.
Jackson JD; Letheby B; O'Kane Murphy B; Costas P; Wang PN; Bishop MR; Kessinger A; Warkentin PI
Prog Clin Biol Res; 1994; 389():471-7. PubMed ID: 7535456
[No Abstract] [Full Text] [Related]
26. CD34 analysis in peripheral blood correlates with colony forming capacity--an update.
Fritsch G; Emminger W; Buchinger P; Printz D; Gadner H
Prog Clin Biol Res; 1992; 377():531-6. PubMed ID: 1279721
[No Abstract] [Full Text] [Related]
27. Murine stromal cell line HESS-5 maintains reconstituting ability of Ex vivo-generated hematopoietic stem cells from human bone marrow and cytokine-mobilized peripheral blood.
Shimakura Y; Kawada H; Ando K; Sato T; Nakamura Y; Tsuji T; Kato S; Hotta T
Stem Cells; 2000; 18(3):183-9. PubMed ID: 10840071
[TBL] [Abstract][Full Text] [Related]
28. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
[TBL] [Abstract][Full Text] [Related]
29. Human umbilical cord blood hematopoietic progenitor cells: are they the same as their adult bone marrow counterparts?
Traycoff CM; Abboud MR; Laver J; Clapp DW; Hoffman R; Law P; Srour EF
Blood Cells; 1994; 20(2-3):382-90; discussion 390-1. PubMed ID: 7538343
[TBL] [Abstract][Full Text] [Related]
30. The composition of CD34 subpopulations differs between bone marrow, blood and cord blood.
Fritsch G; Stimpfl M; Kurz M; Printz D; Buchinger P; Fischmeister G; Hoecker P; Gadner H
Bone Marrow Transplant; 1996 Feb; 17(2):169-78. PubMed ID: 8640162
[TBL] [Abstract][Full Text] [Related]
31. Characterisation and biology of normal human haematopoietic stem cells.
Ploemacher RE
Haematologica; 1999 Jun; 84 Suppl EHA-4():4-7. PubMed ID: 10907454
[No Abstract] [Full Text] [Related]
32. Monitoring of kinetics of CD34 positive cells by immunomagnetic beads during peripheral blood stem cell harvest for autotransplantation.
Oku N; Shimazaki C; Ashihara E; Ohkawa K; Gotoh H; Inaba T; Murakami S; Itoh K; Fujita N; Tsuji H
Prog Clin Biol Res; 1992; 377():553-60. PubMed ID: 1279724
[No Abstract] [Full Text] [Related]
33. Candidate hematopoietic stem cells from fetal tissues, umbilical cord blood vs. adult bone marrow and mobilized peripheral blood.
Huang S; Law P; Young D; Ho AD
Exp Hematol; 1998 Nov; 26(12):1162-71. PubMed ID: 9808056
[TBL] [Abstract][Full Text] [Related]
34. CD34 may be used to determine the adequacy of a stem cell harvest for hematologic recovery following high dose chemotherapy.
Zimmerman TM; Lee WJ; Bender JG; Mick R; Williams SF
Prog Clin Biol Res; 1994; 389():303-8. PubMed ID: 7535435
[No Abstract] [Full Text] [Related]
35. Peripheral blood stem cell rescue in children with advanced stage neuroblastoma.
Kletzel M; Longino R; Danner K; Olszewski M; Moss T
Prog Clin Biol Res; 1994; 389():513-9. PubMed ID: 7535461
[No Abstract] [Full Text] [Related]
36. Enrichment of bone marrow and blood progenitor (CD34+) cells by density gradients with sufficient yields for transplantation.
Schriber JR; Dejbakhsh-Jones S; Kusnierz-Glaz CR; Ginzton N; Still B; Negrin RS; Greenberg P; Strober S
Exp Hematol; 1995 Aug; 23(9):1024-9. PubMed ID: 7543414
[TBL] [Abstract][Full Text] [Related]
37. Expansion of human umbilical cord blood CD34+ hematopoietic progenitor cells with recombinant growth factors.
Akabutu JJ; Chan JR
Prog Clin Biol Res; 1994; 389():399-404. PubMed ID: 7535448
[No Abstract] [Full Text] [Related]
38. Ex vivo expansion of cord blood-derived stem cells and progenitors.
Moore MA; Hoskins I
Blood Cells; 1994; 20(2-3):468-79; discussion 479-81. PubMed ID: 7538352
[TBL] [Abstract][Full Text] [Related]
39. Cytokine-dependent ex vivo expansion of early subsets of CD34+ cord blood myeloid progenitors is enhanced by cord blood plasma, but expansion of the more mature subsets of progenitors is favored.
Ruggieri L; Heimfeld S; Broxmeyer HE
Blood Cells; 1994; 20(2-3):436-54. PubMed ID: 7538350
[TBL] [Abstract][Full Text] [Related]
40. Comparative analysis of peripheral stem cells collected and transplanted in combination with granulocyte-macrophage and granulocyte colony-stimulating factors.
Handgretinger R; Klingebiel T; Herter M; Lang P; Gisselhart A; Dopfer R; Scheel-Walter H; Ehrlich H; Niethammer D
Prog Clin Biol Res; 1994; 389():479-86. PubMed ID: 7535457
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
